Cargando…
A High-Protein and Low-Glycemic Formula Diet Improves Blood Pressure and Other Hemodynamic Parameters in High-Risk Individuals
Low-caloric formula diets can improve hemodynamic parameters of patients with type 2 diabetes. We, therefore, hypothesized that persons with overweight or obesity can benefit from a high-protein, low-glycemic but moderate-caloric formula diet. This post-hoc analysis of the Almased Concept against Ov...
Autores principales: | Röhling, Martin, Kempf, Kerstin, Banzer, Winfried, Braumann, Klaus Michael, Führer-Sakel, Dagmar, Halle, Martin, McCarthy, David, Martin, Stephan, Scholze, Jürgen, Toplak, Hermann, Berg, Aloys, Predel, Hans-Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003071/ https://www.ncbi.nlm.nih.gov/pubmed/35406053 http://dx.doi.org/10.3390/nu14071443 |
Ejemplares similares
-
Prediabetes Conversion to Normoglycemia Is Superior Adding a Low-Carbohydrate and Energy Deficit Formula Diet to Lifestyle Intervention—A 12-Month Subanalysis of the ACOORH Trial
por: Röhling, Martin, et al.
Publicado: (2020) -
High-Protein, Low-Glycaemic Meal Replacement Decreases Fasting Insulin and Inflammation Markers—A 12-Month Subanalysis of the ACOORH Trial
por: Kempf, Kerstin, et al.
Publicado: (2021) -
High-Protein, Low-Glycaemic Meal Replacement Improves Physical Health-Related Quality of Life in High-Risk Persons for Metabolic Syndrome—A Subanalysis of the Randomised-Controlled ACOORH Trial
por: Kempf, Kerstin, et al.
Publicado: (2022) -
Early and Strong Leptin Reduction Is Predictive for Long-Term Weight Loss during High-Protein, Low-Glycaemic Meal Replacement—A Subanalysis of the Randomised-Controlled ACOORH Trial
por: Kempf, Kerstin, et al.
Publicado: (2022) -
Effects of a Protein-Rich, Low-Glycaemic Meal Replacement on Changes in Dietary Intake and Body Weight Following a Weight-Management Intervention—The ACOORH Trial
por: Röhling, Martin, et al.
Publicado: (2021)